# Combining Doxycycline With Bone-Targeted Therapy in Patients With Metastatic Breast Cancer

> **NCT01847976** · PHASE2 · COMPLETED · sponsor: **Ottawa Hospital Research Institute** · enrollment: 73 (actual)

## Conditions studied

- Pain

## Interventions

- **DRUG:** Doxycycline

## Key facts

- **NCT ID:** NCT01847976
- **Lead sponsor:** Ottawa Hospital Research Institute
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-08
- **Primary completion:** 2017-11
- **Final completion:** 2017-11
- **Target enrollment:** 73 (ACTUAL)
- **Last updated:** 2019-09-06

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01847976

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01847976, "Combining Doxycycline With Bone-Targeted Therapy in Patients With Metastatic Breast Cancer". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01847976. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*